Stock listing
Cloudbreak Pharma, Inc.
Selected listing: 2592 · HKEX · HKD · HK
Cloudbreak Pharma, Inc. (HKEX:2592), Health Technology. Latest release Sep 30, 2026: FORMATION OF AN INDEPENDENT SPECIAL COMMITTEE& x3b; DELAY IN PUBLICATION…
- Ticker
- HKEX:2592
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
About Cloudbreak Pharma, Inc.
Cloudbreak Pharma, Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 2592. Cloudbreak Pharma focuses on developing innovative pharmaceutical solutions.
Latest news from Cloudbreak Pharma, Inc.
FORMATION OF AN INDEPENDENT SPECIAL COMMITTEE; DELAY IN PUBLICATION AND DESPATCH OF 2026 INTERIM REPORT; AND CONTINUED SUSPENSION OF TRADING
September 30, 2026
Cloudbreak Pharma Announces Results of First-of-Its-Kind Patient Survey on Pinguecula, Confirming Significant Unmet Need and Impact on Quality of Life
June 22, 2026
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
June 4, 2026
Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum
May 12, 2026
Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026
April 22, 2026
Research Cloudbreak Pharma, Inc.
Cloudbreak Pharma, Inc. company profile
View the public company page for Cloudbreak Pharma, Inc. on 6ix.
Cloudbreak Pharma, Inc. news
Read company news and market updates connected to Cloudbreak Pharma, Inc..
Cloudbreak Pharma, Inc. investor events
Find investor webinars, events, and replay context for Cloudbreak Pharma, Inc..